Le Travenues [IXIGO] vs Tboteck [TBOTEK] Detailed Stock Comparison
Le Travenues
NSE
Loading...
Tboteck
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Le Travenues wins in 5 metrics, Tboteck wins in 13 metrics, with 0 ties. Tboteck appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Le Travenues | Tboteck | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 141.54 | 61.88 | Tboteck |
| Price-to-Book Ratio | 14.42 | 11.84 | Tboteck |
| Debt-to-Equity Ratio | 6.32 | 17.92 | Le Travenues |
| PEG Ratio | 0.79 | 38.67 | Le Travenues |
| EV/EBITDA | 81.71 | 45.33 | Tboteck |
| Profit Margin (TTM) | 6.05% | 13.23% | Tboteck |
| Operating Margin (TTM) | 7.11% | 18.54% | Tboteck |
| EBITDA Margin (TTM) | 7.11% | 18.54% | Tboteck |
| Return on Equity | 9.46% | 26.43% | Tboteck |
| Return on Assets (TTM) | 6.65% | 3.13% | Le Travenues |
| Free Cash Flow (TTM) | $1.18B | $2.36B | Tboteck |
| 1-Year Return | 44.03% | -21.39% | Le Travenues |
| Price-to-Sales Ratio (TTM) | 8.61 | 8.15 | Tboteck |
| Enterprise Value | $88.25B | $139.42B | Tboteck |
| EV/Revenue Ratio | 8.29 | 8.02 | Tboteck |
| Gross Profit Margin (TTM) | 83.38% | 69.70% | Le Travenues |
| Revenue per Share (TTM) | $27 | $164 | Tboteck |
| Earnings per Share (Diluted) | $1.66 | $21.51 | Tboteck |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Le Travenues vs Tboteck Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Le Travenues | -2.30% | 1.88% | 36.94% | 56.00% | 56.79% | 31.03% |
| Tboteck | -0.18% | -3.79% | 0.03% | 18.72% | -17.54% | -22.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Le Travenues | 44.03% | 39.02% | 39.02% | 39.02% | 39.02% | 39.02% |
| Tboteck | -21.39% | -6.20% | -6.20% | -6.20% | -6.20% | -6.20% |
Performance & Financial Health Analysis: Le Travenues vs Tboteck
| Metric | IXIGO | TBOTEK |
|---|---|---|
| Market Information | ||
| Market Cap | ₹91.73B | ₹141.60B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 4,134,325 | 97,020 |
| 90 Day Avg. Volume | 7,765,107 | 164,997 |
| Last Close | ₹234.95 | ₹1,361.70 |
| 52 Week Range | ₹117.00 - ₹246.70 | ₹996.00 - ₹2,001.00 |
| % from 52W High | -4.76% | -31.95% |
| All-Time High | ₹246.70 (Aug 05, 2025) | ₹2,001.00 (Sep 02, 2024) |
| % from All-Time High | -4.76% | -31.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.73% | 0.21% |
| Quarterly Earnings Growth | 0.29% | 0.26% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.13% |
| Operating Margin (TTM) | 0.07% | 0.19% |
| Return on Equity (TTM) | 0.09% | 0.26% |
| Debt to Equity (MRQ) | 6.32 | 17.92 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹16.30 | ₹112.42 |
| Cash per Share (MRQ) | ₹9.46 | ₹106.51 |
| Operating Cash Flow (TTM) | ₹678.52M | ₹2.89B |
| Levered Free Cash Flow (TTM) | ₹601.82M | ₹-259,557,504 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Le Travenues vs Tboteck
| Metric | IXIGO | TBOTEK |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 141.54 | 61.88 |
| Forward P/E | 67.64 | 38.67 |
| PEG Ratio | 0.79 | 38.67 |
| Price to Sales (TTM) | 8.61 | 8.15 |
| Price to Book (MRQ) | 14.42 | 11.84 |
| Market Capitalization | ||
| Market Capitalization | ₹91.73B | ₹141.60B |
| Enterprise Value | ₹88.25B | ₹139.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.29 | 8.02 |
| Enterprise to EBITDA | 81.71 | 45.33 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | ₹16.30 | ₹112.42 |
Financial Statements Comparison: Le Travenues vs Tboteck
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IXIGO | TBOTEK |
|---|---|---|
| Revenue/Sales | ₹2.84B | ₹5.11B |
| Cost of Goods Sold | ₹464.00M | ₹1.78B |
| Gross Profit | ₹2.38B | ₹3.33B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹217.98M | ₹633.04M |
| EBITDA | ₹274.10M | ₹861.70M |
| Pre-Tax Income | ₹238.90M | ₹753.12M |
| Income Tax | ₹71.19M | ₹123.44M |
| Net Income (Profit) | ₹167.71M | ₹629.68M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IXIGO | TBOTEK |
|---|---|---|
| Cash & Equivalents | ₹810.53M | ₹9.62B |
| Total Current Assets | ₹5.63B | ₹57.99B |
| Total Current Liabilities | ₹2.57B | ₹48.37B |
| Long-Term Debt | ₹37.57M | ₹1.57B |
| Total Shareholders Equity | ₹6.36B | ₹11.95B |
| Retained Earnings | N/A | ₹6.97B |
| Property, Plant & Equipment | ₹89.95M | ₹1.09B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IXIGO | TBOTEK |
|---|---|---|
| Operating Cash Flow | ₹-25.51M | ₹-7.06B |
| Capital Expenditures | ₹-3.88M | ₹-21.30M |
| Free Cash Flow | ₹-43.75M | ₹1.74B |
| Debt Repayment | N/A | ₹-15.32M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IXIGO | TBOTEK |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 4,134,325 | 97,020 |
| Average Daily Volume (90 Day) | 7,765,107 | 164,997 |
| Shares Outstanding | 390.11M | 106.30M |
| Float Shares | 159.83M | 33.17M |
| % Held by Insiders | 0.35% | 0.71% |
| % Held by Institutions | 0.48% | 0.21% |
Dividend Analysis & Yield Comparison: Le Travenues vs Tboteck
| Metric | IXIGO | TBOTEK |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |